Sharepoint
Mortgage
Currency
Teeth Whitening
SAP
Nouvelles de SAP
SAP Nachrichten
Obituary
Software As A Service
Bluetooth
Product Recall
Personal Injury
DUI
Business Software
Medical Billing Software
Laser Hair Removal
Plastic Surgery
Adipex
Phentermine
Petroleum Engineering
Offshore Engineering
CA
|
Preliminary results from CINJ's Celebrex and Lipitor Phase II combination trial on prostrate cancer
Research from The Cancer Institute of New Jersey (CINJ) on the FDA-approved drugs Celebrex and Lipitor -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer.
Arthritis and Cholesterol Drugs Well Tolerated in Prostate Cancer Treatment
Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex(r) and Lipitor(r) -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer. Preliminary results from an ongoing Phase II clinical trial will be presented this week during the 2012 Genitourinary Cancers Symposium.
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of ...
NEW YORK , Jan. 12, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis ...
Press Release
GBI Research, the leading business intelligence provider, has released its latest report, Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014 . The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Research and Markets: Musculoskeletal Disorders Therapeutics Market to 2017 - Moderate Growth as Generic Share ...
Research and Markets has announced the addition of the "Musculoskeletal Disorders Therapeutics Market to 2017
En la Revista Crítica
Is Ultram The Same As Tramadol Damage From Lipitor Herbal Hoodia Phentermine How Celebrex Works Buy Levitra Vardenafil Alprazolam Prescription Buy Carisoprodol Who Invented Xanax Link Online Suggest Viagra Tenuate Dospan Cheap Flexeril Diflucan Euphoria Disorder Viagra Premature Celecoxib Dose Lipitor Vs Zocor Female Male Viagra Order Viagra Now Can Levitra Be Broken In Half Order Diazepam ...
John Helou named President of Pfizer Canada Inc.
KIRKLAND, QC, Feb. 8, 2012 /CNW Telbec/ - John Helou has been named President of Pfizer Canada Inc., Canada's largest pharmaceutical company, effective January 31, 2012 . Mr. Helou , a veteran of more ...
Overview of 4Q sales trends for Pfizer medicines
Here are sales figures for the fourth quarter for top-selling Pfizer prescription drugs:PRODUCT NAME MAIN CONDITION/USE 4Q 2011 SALES 4Q 2010 SALES PERCENT CHANGELipitor High cholesterol $2 billion $2.63 ...
Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
NEW YORK, Feb. 8, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market ...
Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic Drug Development
NEW YORK , Jan. 10, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic ...
|
John Helou named President of Pfizer Canada Inc.
KIRKLAND, QC, Feb. 8, 2012 /CNW Telbec/ - John Helou has been named President of Pfizer Canada Inc., Canada's largest pharmaceutical company, effective January 31, 2012 . Mr. Helou , a veteran of more ...
Deadly Dangers from Drugstore Pain Meds a Painful Surprise
Could the painkillers in your medicine cabinet be putting you at risk for heart attack, stroke and liver disease? Recent research suggests that both ibuprofen and acetominophen -- the two most popular over-the-counter painkillers -- carry some potentially and even deadly risks.
New Thermobalancing Therapy Treats Inflammation of Sciatic Nerve Naturally with Long Term Sciatica Relief States Fine ...
Contrary to risky painkillers widely used for sciatica treatment, Dr. Allen’s therapeutic device treats an inflammation of the Sciatic nerve naturally. Fine Treatment recommends Dr. Allen's device to lower back pain sufferers helping them to eliminate pain and avoid different complications.London, UK (PRWEB) January 13, 2012 Fine Treatment recommends the Thermobalancing Therapy as a natural ...
As more drugs go generic, could you be saving money?
Between last year and this year, at least 42 brand-name drugs have lost or are expected to lose their patents and become available as generics, creating as much as $900 million in annual savings in Upstate New York, according to Excellus BlueCross BlueShield.
Study examines link between blood pressure and risk of ESRD under 'real world' conditions
An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease.
Treatment with clot-busting drugs safe for patients with wake-up stroke
Clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2012.
Celebrex News - Get the Latest Celebrex News
|
|